Health Care, Pharmaceuticals, Biotech,
Civil Litigation
Jun. 2, 2021
Judge denies many untimely filed plaintiffs’ documents in opioid trial
Since the trial began in April, Orange County Superior Court Judge Peter Wilson has made several comments expressing discontent over the amount of court time wasted due to document disputes.
A judge denied multiple requests from the plaintiffs to admit untimely filed documents Tuesday as four drug companies prepared to present their defense in a $50 billion bench trial in Orange County.
They are accused of false advertising that fueled California's opioid epidemic.
Since the trial began in April, Orange County Superior Court Judge
Or access this article for $45
Already a subscriber?
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$895, but save $100 when you subscribe today… Just $795 for the first year!
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Sign In
Enewsletter Sign-up
Related Content
Health Care, Pharmaceuticals, Biotech, Civil Litigation
Allergan says there’s no false advertising if public never sees it
By Blaise Scemama
Health Care, Pharmaceuticals, Biotech
4 pharma companies say state has not made its case in Orange County trial
By Blaise Scemama
Health Care, Pharmaceuticals, Biotech, Civil Litigation
Opioid MDL against McKinsey heads to San Francisco
By Blaise Scemama
Health Care, Pharmaceuticals, Biotech, Civil Litigation
Judge gets several 1,000-page motions from opioid trial plaintiffs
By Blaise Scemama
Civil Litigation
State drops 2 opioid defendants, judge mulls total dismissal
By Blaise Scemama
Criminal, 9th U.S. Circuit Court of Appeals
Defenders seek review of panel’s reinstatement of doctor’s opioid trial
By Gina Kim
Constitutional Law, Civil Litigation
Opioid trials remind us of importance of Brady rights
By Nina Marino
Health Care, Pharmaceuticals, Biotech, Civil Litigation
State witness says drugmakers paid for positive opioid studies
By Blaise Scemama
Environmental & Energy, Civil Litigation
Lawyer for wildfire plaintiffs draws judicial rebuke
By Gina Kim
Health Care, Pharmaceuticals, Biotech, Civil Litigation
State’s expert admits bias against opioids
By Blaise Scemama
